共 84 条
[1]
Cooperberg MR(2003)National practice patterns and time trends in androgen ablation for localized prostate cancer J Natl Cancer Inst 95 981-989
[2]
Grossfeld GD(2006)Androgen-deprivation therapy as primary treatment for localized prostate cancer: data from Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE) Cancer 106 1708-1714
[3]
Lubeck DP(2008)Use of androgen deprivation therapy for metastatic prostate cancer in older men BJU Int 101 1077-1083
[4]
Kawakami J(2007)Trends in treatment costs for localized prostate cancer: the healthy screenee effect Med Care 45 154-159
[5]
Cowan JE(2009)Impact of androgen deprivation therapy on cardiovascular disease and diabetes J Clin Oncol 27 3452-3458
[6]
Elkin EP(2006)The rising prevalence of androgen deprivation among older American men since the advent of prostate-specific antigen testing: a population-based cohort study BJU Int 98 973-978
[7]
Keating NL(2007)Influence of androgen suppression therapy for prostate cancer on the frequency and timing of fatal myocardial infarctions J Clin Oncol 25 2420-2425
[8]
O’Malley AJ(2010)Diabetes and cardiovascular disease during androgen deprivation therapy: observational study of veterans with prostate cancer J Natl Cancer Inst 102 39-46
[9]
McNaughton-Collins M(2006)Diabetes and cardiovascular disease during androgen deprivation therapy for prostate cancer J Clin Oncol 24 4448-4456
[10]
Zeliadt SB(2007)Rising PSA in nonmetastatic prostate cancer Oncology 21 1436-1445